| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/22/2003 | EP1276849A2 Albumin fusion proteins |
| 01/22/2003 | EP1276764A1 Human polynucleotides, polypeptides, and antibodies |
| 01/22/2003 | EP1276762A1 Porphyromonas gingivalis recombinant proteins and truncations |
| 01/22/2003 | EP1276760A2 Polyamide nucleic acid derivatives, agents and methods for producing them |
| 01/22/2003 | EP1276755A1 Novel compounds |
| 01/22/2003 | EP1276747A1 The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals |
| 01/22/2003 | EP1276739A2 Heterocycles that are inhibitors of impdh enzyme |
| 01/22/2003 | EP1276738A1 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors |
| 01/22/2003 | EP1276734A1 Halogenated rhodamine derivatives and applications thereof |
| 01/22/2003 | EP1276731A2 Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht 1a activity |
| 01/22/2003 | EP1276725A2 5-substituted tetralones as inhibitors of ras farnesyl transferase |
| 01/22/2003 | EP1276503A2 Compositions comprising an inhibitor of an acrab-like efflux pump for reducing microbial resistance to drugs |
| 01/22/2003 | EP1276495A1 Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases |
| 01/22/2003 | EP1276491A1 Tamandarin and didemnin analogs and methods of making and using them |
| 01/22/2003 | EP1276488A1 Use of lactic acid bacterium for the treatment of peritonitis |
| 01/22/2003 | EP1276468A1 Use of particulate vectors in immunomodulation |
| 01/22/2003 | EP1276392A2 Nutritional modules |
| 01/22/2003 | EP1242079A4 Methods of use of fluoroquinolone compounds againts bacteria |
| 01/22/2003 | EP1107738A4 Novel pharmaceutical salt form |
| 01/22/2003 | EP1070078B1 Form vi 5,6-dichloro-2-(isopropylamino)-1-beta-l-ribofuranosyl)-1h-benzimidazole |
| 01/22/2003 | EP0942721B1 Liquid composition comprising an hiv protease inhibitor and a c12-c18 fatty acid |
| 01/22/2003 | EP0842180B1 Penam sulfones as beta-lactamase inhibitors |
| 01/22/2003 | EP0775115B1 Dimeric arylisoquinoline alkaloids and synthesis methods thereof |
| 01/22/2003 | EP0729465B1 Pyrone derivatives as protease inhibitors and antiviral agents |
| 01/22/2003 | EP0610436B1 Hepatitis-c virus testing |
| 01/22/2003 | CN1392154A Antisense nucleic acid with virus infection inhibiting function |
| 01/22/2003 | CN1392146A Water cress extract and its preparing method and use |
| 01/22/2003 | CN1391946A Saussurea involucrata liquid for relaxing yin |
| 01/22/2003 | CN1391942A New medicine for anti-cancer, anti-AIDs and giving-up drug habits and its preparing and applying method |
| 01/22/2003 | CN1391931A Medicine for curing herpes zoster |
| 01/22/2003 | CN1391902A Use of rare-earth nitrate, sulfate, chloride in preparing medicine for curing AIDs |
| 01/22/2003 | CN1391899A Aseptic freeze-dried prostaglandin injection and its preparing method and use |
| 01/22/2003 | CN1099462C Medical composition |
| 01/22/2003 | CN1099460C Chicken merek's disease virus genic mutant strain and its use |
| 01/22/2003 | CN1099417C New polycyclic 2,3-phthalazine derivatives and their use |
| 01/22/2003 | CN1099295C Infectious cloacal bursa virus vaccine for chicken and its preparing process and application |
| 01/22/2003 | CN1099292C Chinese herbal medicine for preventing and curing diseases of fishes and shrimps |
| 01/21/2003 | US6509446 Recombinant genetic information (DNA or RNA), consisting a Chicken Anemia Virus (CAV)-specific nucleotide sequence, useful for diagonestics, vaccination or protein production |
| 01/21/2003 | US6509443 Amino acid residue located at position 63 of native-sequence human Insulin like Growth Factor-I is replaced with an alanine residue or amino acid residues at positions 1 and 70 are replaced with serine and valine respectively |
| 01/21/2003 | US6509365 Useful as inhibitors of poly(ADP-ribose)polymerase and for the production of drugs. |
| 01/21/2003 | US6509363 P38 is a mitogen-activated protein kinase; pyrrole, oxazole, thiazole, and imidazole derivatives |
| 01/21/2003 | US6509351 A method of inhibiting TNF- alpha in a patient in need thereof which comprises administering to said patient an effective amount of a compound for inflamation |
| 01/21/2003 | US6509349 Antimicrobial 2-pyridones, their compositions and uses |
| 01/21/2003 | US6509346 Chemokine receptor antagonists and methods of use therefor |
| 01/21/2003 | US6509325 Method for inhibiting melanogenesis and uses thereof |
| 01/21/2003 | US6509321 Treatment of Kaposi's sarcoma with IL-12 |
| 01/21/2003 | US6509313 Stimulation of immune response with low doses of cytokines |
| 01/21/2003 | US6509177 Cultivating on a medium comprising at least one organic nitrogen or carbon source, in submerged aerated conditions, a Pseudomonas bacterium strain capable of the biosynthesis of pseudomonic acid A |
| 01/21/2003 | US6509154 Product comprising at least a double stranded RNA combined with at least an antiviral agent |
| 01/21/2003 | US6509151 DNA molecule encoding a Mycobacterium protein and conferring on Mycobacterium tuberculosis an ability to enter mammalian cells and to survive within macrophages |
| 01/21/2003 | US6509042 Anti viral composition |
| 01/21/2003 | US6509017 Vaccines containing nucleic acid fragments encoding antigenic proteins that increase resistance to infection; isolated, purified polypeptide having amino acid sequence 1-598 of seq id no: 6 or 1-600 of seq id no: 8 |
| 01/21/2003 | US6509015 Human antibodies that bind human TNFa |
| 01/21/2003 | US6508585 Differential scanning calorimeter |
| 01/21/2003 | CA1341418C Substantially-pure non-inflammatory hyaluronic acid |
| 01/17/2003 | WO2002006214A1 Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
| 01/17/2003 | CA2415954A1 Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
| 01/16/2003 | WO2003005035A1 Chp for use as marker for sepsis-type inflammatory diseases |
| 01/16/2003 | WO2003004668A1 Process for the production of allicin |
| 01/16/2003 | WO2003004657A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | WO2003004650A2 Group b streptococcus antigens and corresponding dna fragments |
| 01/16/2003 | WO2003004627A2 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 01/16/2003 | WO2003004620A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | WO2003004608A2 Drug metabolizing enzymes |
| 01/16/2003 | WO2003004526A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses and their use as medicines |
| 01/16/2003 | WO2003004520A2 Mycobacterial antigens expressed during latency |
| 01/16/2003 | WO2003004511A2 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 01/16/2003 | WO2003004509A2 C12 modified erythromycin macrolides and ketolides having antibacterial activity |
| 01/16/2003 | WO2003004507A1 A kind of oligosaccharides, their sulfates and dendrimers, and the uses of these compounds |
| 01/16/2003 | WO2003004498A1 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 01/16/2003 | WO2003004489A1 Compositions and methods for inhibiting prenyltransferases |
| 01/16/2003 | WO2003004487A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 01/16/2003 | WO2003004479A1 4-aryl quinols and analogs thereof as therapeutic agents |
| 01/16/2003 | WO2003004473A1 Novel butadiene derivatives, process for preparation of the same and intermediates for the synthesis thereof |
| 01/16/2003 | WO2003004472A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 01/16/2003 | WO2003004467A2 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 01/16/2003 | WO2003004461A1 Drugs for treating viral infections |
| 01/16/2003 | WO2003004098A1 Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 01/16/2003 | WO2003004065A1 Method of transporting physiological polymer using protein having rxp repeated sequence |
| 01/16/2003 | WO2003004054A1 Ltb4 as vaccine aduvant |
| 01/16/2003 | WO2003004052A1 Mycoplasma bovis vaccine and methods of reducing pneumonia in animals |
| 01/16/2003 | WO2003004051A2 Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle |
| 01/16/2003 | WO2003004049A2 Use of polyclonal anti-hiv goat serum as a therapeutic agent |
| 01/16/2003 | WO2003004023A1 1-alkyl-2-aryl-benzimidazole derivatives, their use for producing medicaments and pharmaceutical preparations containing said derivatives |
| 01/16/2003 | WO2003004016A1 Use of substituted gamma-lactone compounds as medicaments |
| 01/16/2003 | WO2003004004A1 Pharmacological preparation made from a nanoparticulate mesomorphous polyelectrolyte lipid complex and at least one active ingredient |
| 01/16/2003 | WO2003003979A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 01/16/2003 | WO2003003941A2 One dose vaccination with mycoplasma hyopneumoniae |
| 01/16/2003 | WO2003003833A1 Antiviral composition and treatment method |
| 01/16/2003 | WO2002088178A3 Antigens of group b streptococcus and corresponding dna fragments |
| 01/16/2003 | WO2002085387A3 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent ans their use in the treatment of inflammatory skin conditions |
| 01/16/2003 | WO2002085386A3 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue |
| 01/16/2003 | WO2002085385A3 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa |
| 01/16/2003 | WO2002076930A3 Substituted diarylureas as stimulators for fas-mediated apoptosis |
| 01/16/2003 | WO2002072527A3 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof |
| 01/16/2003 | WO2002059148A8 A method for identification, isolation and production of antigens to a specific pathogen |
| 01/16/2003 | WO2002045683A3 Reversible gelling system for ocular drug delivery |
| 01/16/2003 | WO2002040016A3 Association of calpain inhibitors and reactive oxygen species trapping agents |
| 01/16/2003 | WO2002038177A3 Adjuvant combination formulations |
| 01/16/2003 | WO2002034769A3 Immunoreactive peptide ctl epitopes of human cytomegalovirus pp150 |